Beximco Pharmaceuticals 

GBX42.5
17
+GBX2.5+6.25% Tuesday 11:41

Statistics

Day High
42
Day Low
42
52W High
52.33
52W Low
0.43
Volume
1,220,000
Avg. Volume
51,185
Mkt Cap
189.6M
P/E Ratio
5.31
Dividend Yield
6.12%
Dividend
2.6

Upcoming

Dividends

6.12%Dividend Yield
Feb 26
GBX2.6
Feb 25
GBX2.6
Feb 24
GBX2.6
Mar 23
GBX2.8
Feb 22
GBX2.94
10Y Growth
18.65%
5Y Growth
-2.4%
3Y Growth
0.06%
1Y Growth
N/A

Earnings

11NovExpected
Q3 2020
Q4 2020
Q1 2021
Q3 2021
Q4 2021
Q1 2022
Q3 2022
2.14
2.54
2.93
3.32
Expected EPS
N/A
Actual EPS
2.8679

Financials

13.18%Profit Margin
Profitable
2018
2019
2020
2021
2022
2023
7.02TRevenue
925.74BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BXP.LSE. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Innoviva
INVA
Mkt Cap1.72B
InvaGen Pharmaceuticals Inc. competes in the generics market, offering a portfolio that overlaps with Beximco's, particularly in the US market.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap35.03B
Teva Pharmaceutical Industries Limited is a global leader in generic medicines, directly competing with Beximco's offerings in multiple international markets.
Dr. Reddy`s Laboratories
RDY
Mkt Cap11.12B
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company that competes with Beximco in the generics and active pharmaceutical ingredients (API) sectors.
Accenture
ACN
Mkt Cap123.91B
ACME Laboratories Ltd. is another key competitor in the Bangladeshi pharmaceutical sector, competing directly with Beximco in terms of product range and market share.
GSK
GSK
Mkt Cap113.29B
GlaxoSmithKline plc is a global pharmaceutical company whose diverse product line in pharmaceuticals and vaccines competes with Beximco's products in various markets.
Novartis
NVS
Mkt Cap297.32B
Novartis AG is a Swiss multinational pharmaceutical company that competes with Beximco in the development and marketing of drugs in similar therapeutic areas.
Pfizer
PFE
Mkt Cap161.09B
Pfizer Inc. is a global pharmaceutical corporation that competes with Beximco in the innovation, development, and distribution of pharmaceuticals and vaccines.
Abbvie
ABBV
Mkt Cap369.39B
AbbVie Inc. competes with Beximco through its broad range of pharmaceutical products, particularly in therapeutic areas where Beximco is also active.
Merck
MRK
Mkt Cap298.84B
Merck & Co., Inc. is a global healthcare company that competes with Beximco in the discovery, development, and marketing of pharmaceuticals and vaccines.

About

Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It offers its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.
Show more...
CEO
Mr. Iqbal U. Ahmed
Employees
6000
Country
GB
ISIN
US0885792061

Listings

0 Comments

Share your thoughts

FAQ

What is Beximco Pharmaceuticals stock price today?
The current price of BXP.LSE is GBX42.5 GBX — it has increased by +6.25% in the past 24 hours. Watch Beximco Pharmaceuticals stock price performance more closely on the chart.
What is Beximco Pharmaceuticals stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Beximco Pharmaceuticals stocks are traded under the ticker BXP.LSE.
Is Beximco Pharmaceuticals stock price growing?
BXP.LSE stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Beximco Pharmaceuticals has showed a +16.89% increase.
What is Beximco Pharmaceuticals market cap?
Today Beximco Pharmaceuticals has the market capitalization of 189.6M
What were Beximco Pharmaceuticals earnings last quarter?
BXP.LSE earnings for the last quarter are 2.87 GBX per share, whereas the estimation was N/A GBX resulting in a N/A surprise. The estimated earnings for the next quarter are N/A GBX per share.
What is Beximco Pharmaceuticals revenue for the last year?
Beximco Pharmaceuticals revenue for the last year amounts to 7.02T GBX.
What is Beximco Pharmaceuticals net income for the last year?
BXP.LSE net income for the last year is 925.74B GBX.
Does Beximco Pharmaceuticals pay dividends?
Yes, BXP.LSE dividends are paid annual. The last dividend per share was 2.6 GBX. As of today, Dividend Yield (FWD)% is 6.12%.
How many employees does Beximco Pharmaceuticals have?
As of April 08, 2026, the company has 6,000 employees.
In which sector is Beximco Pharmaceuticals located?
Beximco Pharmaceuticals operates in the Health Care sector.
When did Beximco Pharmaceuticals complete a stock split?
The last stock split for Beximco Pharmaceuticals was on November 23, 2020 with a ratio of 1.1:1.
Where is Beximco Pharmaceuticals headquartered?
Beximco Pharmaceuticals is headquartered in Dhaka, GB.